MAPT and Alzheimer disease: In patients with an etiological diagnosis of AD already supported by a first PET scan, a further change in diagnosis was observed in 36% (9/25) of patients after a negative tau-PET, and in 50% (1/2) after a negative amyloid-PET, with no difference between exams (χ2 = 0, p = 1.00).